Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyomavirus Infections | 14 | 2010 | 45 | 1.190 |
Why?
|
| Polyomavirus | 12 | 2010 | 24 | 1.000 |
Why?
|
| Tumor Virus Infections | 10 | 2010 | 36 | 0.880 |
Why?
|
| Killer Cells, Natural | 6 | 2010 | 219 | 0.650 |
Why?
|
| Antibodies, Viral | 8 | 2009 | 329 | 0.650 |
Why?
|
| T-Lymphocytes | 10 | 2010 | 1019 | 0.490 |
Why?
|
| Immunoglobulin G | 8 | 2010 | 463 | 0.470 |
Why?
|
| B-Lymphocyte Subsets | 3 | 2009 | 46 | 0.370 |
Why?
|
| Mice, Knockout | 15 | 2011 | 2140 | 0.320 |
Why?
|
| B-Lymphocytes | 8 | 2007 | 571 | 0.300 |
Why?
|
| Lymphocyte Activation | 6 | 2010 | 761 | 0.290 |
Why?
|
| Immunologic Memory | 3 | 2007 | 290 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 17 | 2010 | 3450 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2007 | 679 | 0.280 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2007 | 645 | 0.270 |
Why?
|
| Mice | 25 | 2011 | 11003 | 0.270 |
Why?
|
| Animals | 28 | 2011 | 20961 | 0.220 |
Why?
|
| Virus Diseases | 2 | 2004 | 123 | 0.220 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2009 | 247 | 0.210 |
Why?
|
| Antigens, T-Independent | 3 | 2009 | 10 | 0.210 |
Why?
|
| Trisaccharides | 1 | 2011 | 9 | 0.170 |
Why?
|
| Galactosyltransferases | 1 | 2011 | 16 | 0.170 |
Why?
|
| Capsid Proteins | 3 | 2006 | 103 | 0.170 |
Why?
|
| Mice, SCID | 8 | 2009 | 517 | 0.170 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 671 | 0.170 |
Why?
|
| Glycolipids | 1 | 2011 | 47 | 0.170 |
Why?
|
| Antigens, Viral | 3 | 2007 | 137 | 0.170 |
Why?
|
| Cell Movement | 2 | 2011 | 466 | 0.170 |
Why?
|
| Liposomes | 1 | 2011 | 107 | 0.170 |
Why?
|
| Macrophage Activation | 1 | 2011 | 119 | 0.160 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2010 | 9 | 0.160 |
Why?
|
| DNA Virus Infections | 1 | 2010 | 8 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 2010 | 71 | 0.160 |
Why?
|
| Tularemia | 1 | 2010 | 15 | 0.160 |
Why?
|
| Francisella tularensis | 1 | 2010 | 21 | 0.160 |
Why?
|
| DNA Viruses | 1 | 2010 | 17 | 0.160 |
Why?
|
| Listeriosis | 1 | 2010 | 30 | 0.160 |
Why?
|
| Epitopes | 1 | 2011 | 292 | 0.160 |
Why?
|
| Wound Healing | 1 | 2011 | 192 | 0.150 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2010 | 83 | 0.150 |
Why?
|
| Antibody Formation | 2 | 2007 | 114 | 0.150 |
Why?
|
| Immunoglobulin M | 3 | 2009 | 115 | 0.150 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 155 | 0.150 |
Why?
|
| Antioxidants | 1 | 2010 | 256 | 0.140 |
Why?
|
| Parasitic Diseases | 1 | 1998 | 6 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 309 | 0.140 |
Why?
|
| Immunity, Cellular | 3 | 2006 | 178 | 0.130 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2007 | 60 | 0.130 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2007 | 89 | 0.120 |
Why?
|
| Muromegalovirus | 1 | 2006 | 7 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2007 | 204 | 0.120 |
Why?
|
| Receptors, Complement 3d | 1 | 2006 | 16 | 0.120 |
Why?
|
| Herpesviridae Infections | 1 | 2006 | 27 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 1998 | 153 | 0.120 |
Why?
|
| Cell Differentiation | 4 | 2007 | 1365 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2006 | 223 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 785 | 0.110 |
Why?
|
| Antigen Presentation | 1 | 2007 | 241 | 0.110 |
Why?
|
| Mycoplasma Infections | 1 | 2004 | 6 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2010 | 3070 | 0.110 |
Why?
|
| Scleroderma, Systemic | 1 | 2004 | 21 | 0.110 |
Why?
|
| Macrophages | 1 | 2010 | 1053 | 0.110 |
Why?
|
| Viral Load | 3 | 2010 | 233 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2002 | 182 | 0.110 |
Why?
|
| Centrosome | 1 | 2004 | 71 | 0.110 |
Why?
|
| Viral Envelope Proteins | 1 | 2004 | 102 | 0.100 |
Why?
|
| Autoantibodies | 1 | 2004 | 184 | 0.100 |
Why?
|
| Spleen | 4 | 2009 | 482 | 0.100 |
Why?
|
| Acute Disease | 4 | 2009 | 672 | 0.100 |
Why?
|
| Relapsing Fever | 1 | 2003 | 17 | 0.100 |
Why?
|
| Lymphocyte Depletion | 4 | 2007 | 102 | 0.090 |
Why?
|
| Clonal Anergy | 1 | 2002 | 23 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2010 | 119 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 89 | 0.090 |
Why?
|
| Vaccinia | 1 | 2001 | 32 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 179 | 0.090 |
Why?
|
| Plasma Cells | 1 | 2001 | 52 | 0.090 |
Why?
|
| Capsid | 2 | 2000 | 97 | 0.090 |
Why?
|
| Vaccinia virus | 1 | 2001 | 73 | 0.080 |
Why?
|
| CD3 Complex | 1 | 2001 | 65 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 1196 | 0.080 |
Why?
|
| CD40 Antigens | 1 | 2000 | 60 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2007 | 756 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2010 | 1540 | 0.070 |
Why?
|
| Cell Line | 3 | 2010 | 2055 | 0.070 |
Why?
|
| Clone Cells | 2 | 2009 | 116 | 0.070 |
Why?
|
| Myeloproliferative Disorders | 2 | 1996 | 17 | 0.070 |
Why?
|
| Adoptive Transfer | 2 | 2009 | 149 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2010 | 668 | 0.060 |
Why?
|
| Mice, Inbred CBA | 3 | 2003 | 83 | 0.060 |
Why?
|
| Mice, Inbred C3H | 2 | 2007 | 176 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2007 | 182 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2009 | 197 | 0.060 |
Why?
|
| Immunity, Innate | 3 | 2010 | 803 | 0.060 |
Why?
|
| Lymphocytes | 1 | 1996 | 203 | 0.060 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2007 | 147 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2006 | 73 | 0.050 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1994 | 54 | 0.050 |
Why?
|
| CD40 Ligand | 2 | 2006 | 159 | 0.050 |
Why?
|
| Lymphopenia | 2 | 2003 | 35 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2011 | 22 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2003 | 348 | 0.040 |
Why?
|
| Virion | 2 | 2004 | 121 | 0.040 |
Why?
|
| Genes, T-Cell Receptor beta | 2 | 2001 | 9 | 0.040 |
Why?
|
| Macrophages, Peritoneal | 1 | 2011 | 77 | 0.040 |
Why?
|
| Complement Activation | 1 | 2011 | 47 | 0.040 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2010 | 14 | 0.040 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2010 | 5 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2010 | 10 | 0.040 |
Why?
|
| Rabbits | 1 | 2011 | 333 | 0.040 |
Why?
|
| Cell Separation | 1 | 2010 | 146 | 0.040 |
Why?
|
| Female | 7 | 2007 | 33360 | 0.040 |
Why?
|
| Swine | 1 | 2011 | 394 | 0.040 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2010 | 70 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2010 | 112 | 0.040 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2009 | 9 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 88 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 151 | 0.040 |
Why?
|
| Cytidine Deaminase | 1 | 2010 | 86 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 237 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 891 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 544 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2010 | 614 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 205 | 0.040 |
Why?
|
| Germinal Center | 2 | 1998 | 39 | 0.040 |
Why?
|
| Humans | 8 | 2010 | 64251 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2009 | 587 | 0.030 |
Why?
|
| Viral Plaque Assay | 1 | 2007 | 16 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2002 | 727 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 192 | 0.030 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2007 | 10 | 0.030 |
Why?
|
| Antibody-Producing Cells | 1 | 2007 | 12 | 0.030 |
Why?
|
| Species Specificity | 1 | 2007 | 334 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2007 | 66 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2007 | 53 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 458 | 0.030 |
Why?
|
| Age Factors | 1 | 2010 | 1569 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1494 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2006 | 75 | 0.030 |
Why?
|
| Cytokines | 1 | 2010 | 944 | 0.030 |
Why?
|
| CD28 Antigens | 1 | 2006 | 60 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2006 | 80 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 2006 | 103 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 140 | 0.030 |
Why?
|
| DNA | 1 | 2010 | 844 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 433 | 0.030 |
Why?
|
| Mycoplasma | 1 | 2004 | 8 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2004 | 127 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1597 | 0.030 |
Why?
|
| Autoantigens | 1 | 2004 | 137 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1997 | 0.020 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2003 | 3 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2004 | 275 | 0.020 |
Why?
|
| Blood Bactericidal Activity | 1 | 2003 | 62 | 0.020 |
Why?
|
| Borrelia | 1 | 2003 | 32 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2003 | 76 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 302 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2004 | 240 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2002 | 1 | 0.020 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2002 | 2 | 0.020 |
Why?
|
| Bacteremia | 1 | 2003 | 94 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2002 | 86 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2001 | 17 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2003 | 189 | 0.020 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2001 | 13 | 0.020 |
Why?
|
| Chimera | 1 | 2001 | 42 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2001 | 31 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2001 | 30 | 0.020 |
Why?
|
| Liver | 1 | 2006 | 868 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2001 | 21 | 0.020 |
Why?
|
| Antigens | 1 | 2001 | 149 | 0.020 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2000 | 2 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 430 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2001 | 184 | 0.020 |
Why?
|
| Male | 4 | 2004 | 30305 | 0.020 |
Why?
|
| Virus Replication | 1 | 2001 | 323 | 0.020 |
Why?
|
| Kinetics | 1 | 2001 | 766 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2001 | 291 | 0.020 |
Why?
|
| Ligands | 1 | 2000 | 417 | 0.020 |
Why?
|
| Survival Rate | 1 | 2001 | 859 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 800 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2001 | 342 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2001 | 1297 | 0.020 |
Why?
|
| Vaccination | 1 | 1998 | 371 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1996 | 102 | 0.010 |
Why?
|
| Inflammation | 1 | 2001 | 1162 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1994 | 105 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1994 | 234 | 0.010 |
Why?
|